These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 16387707)
1. Amyloid, cholinesterase, melatonin, and metals and their roles in aging and neurodegenerative diseases. Lahiri DK; Chen DM; Lahiri P; Bondy S; Greig NH Ann N Y Acad Sci; 2005 Nov; 1056():430-49. PubMed ID: 16387707 [TBL] [Abstract][Full Text] [Related]
2. Melatonin, metals, and gene expression: implications in aging and neurodegenerative disorders. Lahiri DK; Chen D; Lahiri P; Rogers JT; Greig NH; Bondy S Ann N Y Acad Sci; 2004 Dec; 1035():216-30. PubMed ID: 15681810 [TBL] [Abstract][Full Text] [Related]
3. Role of melatonin in Alzheimer-like neurodegeneration. Wang JZ; Wang ZF Acta Pharmacol Sin; 2006 Jan; 27(1):41-9. PubMed ID: 16364209 [TBL] [Abstract][Full Text] [Related]
4. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine. Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766 [TBL] [Abstract][Full Text] [Related]
5. Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex. Lahiri DK; Chen D; Ge YW; Bondy SC; Sharman EH J Pineal Res; 2004 May; 36(4):224-31. PubMed ID: 15066046 [TBL] [Abstract][Full Text] [Related]
6. Melatonin prevents amyloid protofibrillar induced oxidative imbalance and biogenic amine catabolism. Gunasingh MJ; Philip JE; Ashok BS; Kirubagaran R; Jebaraj WC; Davis GD; Vignesh S; Dhandayuthapani S; Jayakumar R Life Sci; 2008 Jul; 83(3-4):96-102. PubMed ID: 18590917 [TBL] [Abstract][Full Text] [Related]
7. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. Abdul HM; Calabrese V; Calvani M; Butterfield DA J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066 [TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of melatonin in experimental models of Alzheimer disease. Cheng Y; Feng Z; Zhang QZ; Zhang JT Acta Pharmacol Sin; 2006 Feb; 27(2):129-39. PubMed ID: 16412260 [TBL] [Abstract][Full Text] [Related]
9. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338 [TBL] [Abstract][Full Text] [Related]
10. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
11. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease. Pákáski M; Kálmán J Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955 [TBL] [Abstract][Full Text] [Related]
12. The human pineal gland and melatonin in aging and Alzheimer's disease. Wu YH; Swaab DF J Pineal Res; 2005 Apr; 38(3):145-52. PubMed ID: 15725334 [TBL] [Abstract][Full Text] [Related]
14. Melatonin, human aging, and age-related diseases. Karasek M Exp Gerontol; 2004; 39(11-12):1723-9. PubMed ID: 15582288 [TBL] [Abstract][Full Text] [Related]
15. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Song MS; Rauw G; Baker GB; Kar S Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381 [TBL] [Abstract][Full Text] [Related]
16. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease. Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525 [TBL] [Abstract][Full Text] [Related]
18. Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology. Maynard CJ; Cappai R; Volitakis I; Cherny RA; Masters CL; Li QX; Bush AI J Inorg Biochem; 2006 May; 100(5-6):952-62. PubMed ID: 16574231 [TBL] [Abstract][Full Text] [Related]
19. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease. Xu H; Wang R; Zhang YW; Zhang X Ann N Y Acad Sci; 2006 Nov; 1089():324-42. PubMed ID: 17261779 [TBL] [Abstract][Full Text] [Related]
20. Disturbances in neurotransmission processes in aging and age-related diseases. Ossowska K Pol J Pharmacol; 1993; 45(2):109-31. PubMed ID: 8401765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]